(Updates with share repurchase details in the last paragraph.)

MetLife (MET) reported fiscal Q2 adjusted earnings late Wednesday of $2.43 per diluted share, up from $2.02 a year earlier.

Analysts polled by FactSet expected $2.30.

Revenue for the three months ended June 30 was $19.15 billion, up from $17.34 billion a year earlier.

Analysts expected $19.67 billion.

Also, MetLife said its board has approved a new $3 billion authorization to repurchase its common stock, which is incremental to nearly $400 million remaining under its previous authorization announced in April 2025.